Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis.

Omar Saeed, Lori J Bernstein, Rouhi Fazelzad, Mary Samuels, Lynn A Burmeister, Lehana Thabane, Shereen Ezzat, David P Goldstein, Jennifer Jones, Anna M Sawka

Journal: Journal of cancer survivorship : research and practice 2020;13(2):231-243

PMID: 30949895

Abstract

BACKGROUND

Some thyroid cancer (TC) survivors experience cognitive symptoms.

PURPOSE

The purpose of this study is to perform a systematic literature review and meta-analysis comparing cognitive performance in TC survivors to controls.

METHODS

We performed a seven-database electronic search and hand-search. We performed duplicate independent reviews and data abstraction. Random effects meta-analyses reported standardized mean differences (SMDs) with 95% confidence intervals (CIs), where a negative value implies worse performance in the TC group.

RESULTS

We reviewed 1174 unique citations and 10 full-text papers. We included seven studies of 241 treated TC survivors and 273 controls. Cognitive function was statistically significantly worse in TC survivors in the following domains: Attention and Concentration (Digit Span Forwards) SMD - 0.37 (95% CI - 0.62, - 0.13, p = 0.003, four studies), Speed of Processing (Trail Making A) SMD - 0.36 (95% CI - 0.66, - 0.05, p = 0.022, four studies), and Language (Controlled Oral Word Association [COWAT]-Categories) SMD - 0.97 (95% - 1.31, - 0.64, p < 0.001, two studies). Executive Function results varied: COWAT-Letters SMD - 0.60 (95% CI - 0.94, - 0.27, p < 0.001, two studies), Digit Span Backwards SMD - 0.40 (95% CI - 0.64, - 0.15, p = 0.002, four studies), and Trail Making B test SMD - 0.20 (95% CI - 0.51, 0.10, p = 0.191, four studies). Statistical heterogeneity limited the COWAT-Categories and Digit Span Backwards meta-analyses.

CONCLUSIONS

Cognitive function was worse in TC survivors in multiple domains. Limitations included few studies, potential confounding, and lack of prospective data.

IMPLICATIONS FOR CANCER SURVIVORS

TC survivors may experience impairments in cognitive function and should report cognitive concerns to healthcare practitioners.

Address: Division of Endocrinology, St. Michael's Hospital, Toronto, Canada.; Division of Endocrinology, University of Toronto, Toronto, Canada.; Department of Supportive Care and Department of Psychiatry, University Health Network and University of Toronto, Toronto, Canada.; Princess Margaret Cancer Centre, University Health Network Library and Information Services, Toronto, Canada.; Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health and Science University, Portland, OR, USA.; Division of Diabetes, Endocrinology, and Metabolism, University of Minnesota, Minneapolis, MN, USA.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; Department of Endocrine Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada.; Department of Otolaryngology, Head and Neck Surgery, University Health Network and University of Toronto, Toronto, Canada.; Division of Endocrinology, University of Toronto, Toronto, Canada. [email protected].; Division of Endocrinology, University Health Network (Toronto General Hospital), Toronto, Canada. [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.